Перейти к содержанию

Universe Pharmaceuticals INC (UPC) stock: revenue, earnings & dividend

Universe Pharmaceuticals INC (UPC, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener UPC · Nasdaq Pharma & Biotech CN

Key figures

Fiscal year
2025
Revenue
17.9 bn $
Revenue growth
-22.4 %
Revenue growth 5y (p.a.)
257.2 %
Net income
-3.67 bn $
Net margin
-20.6 %
Operating margin
-16.3 %
Earnings per share (diluted)
-8.06 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
–
Equity
–
Equity ratio
–
Return on equity
–
Cash
–
Operating cash flow
-5.05 bn $
Free cash flow
-5.32 bn $
Shares outstanding
–

History

Revenue by fiscal year

2019 33.2 m $
2020 30.7 m $
2021 48 m $
2022 40.1 m $
2023 32.3 bn $
2024 23 bn $
2025 17.9 bn $

Net income by fiscal year

2020 7.56 m $
2021 11.3 m $
2022 -7.91 m $
2023 -6.58 bn $
2024 -8.73 bn $
2025 -3.67 bn $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202517.9 bn $-3.67 bn $-8.06 $–-5.05 bn $
202423 bn $-8.73 bn $-626.96 $–-9.51 bn $
202332.3 bn $-6.58 bn $-1,089.21 $–1.12 bn $
202240.1 m $-7.91 m $-1,309.11 $–-1.3 m $
202148 m $11.3 m $3.58 $–-2.06 m $
202030.7 m $7.56 m $0.47 $–6.12 m $
201933.2 m $–––13.2 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)